GlobeNewswire: Medivo Contains the last 10 of 6 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T17:32:58ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2015/06/05/742470/10137478/en/Medivo-Abstracts-Selected-for-Publication-by-the-American-Society-of-Clinical-Oncology.html?f=22&fvtc=4&fvtv=25186Medivo Abstracts Selected for Publication by the American Society of Clinical Oncology2015-06-05T13:03:07Z<![CDATA[Studies in Pancreatic Cancer and Chronic Myelogenous Leukemia (CML) highlight the important role of lab testing in getting the right treatments to patients. NEW YORK, N.Y., June 5, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Medivo, Inc., a leader in lab data analytics, had two abstracts selected for publication in conjunction with the 2015 ASCO Annual Meeting, which took place from May 29 - June 2, 2015 in Chicago, IL.]]>https://www.globenewswire.com/news-release/2015/05/22/738494/10135706/en/Medivo-Study-Finds-HCV-Positivity-Rates-are-250-Higher-Among-Baby-Boomers.html?f=22&fvtc=4&fvtv=25186Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers2015-05-22T12:01:52Z<![CDATA[Analysis of over 4,000,000 patients was selected as a Poster of Distinction at Digestive Disease Week. NEW YORK, May 22, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Medivo, Inc., a leader in lab data analytics, presented an abstract entitled "Positivity Rates and Genotype Results in 'Baby Boomers' Screened for HCV Following the 2012 CDC Call to Action: Results from a Nationwide Lab Test Database" at Digestive Disease Week, May 16-19, 2015.]]>https://www.globenewswire.com/news-release/2015/05/15/736349/10134713/en/Medivo-Study-Supports-Link-Between-Diabetes-and-Fatty-Liver-Disease.html?f=22&fvtc=4&fvtv=25186Medivo Study Supports Link Between Diabetes and Fatty Liver Disease2015-05-15T13:57:15Z<![CDATA[Analysis of over 200,000 patients has been selected for a Guided Poster Tour at the upcoming AACE Annual Meeting NEW YORK, N.Y., May 15, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Medivo, Inc., a leader in lab data analytics, will be presenting an abstract entitled "ELEVATED AST AND ALT RESULTS AND AN AST/ALT RATIO BETWEEN 0.7 AND 1.0 LINKED TO AN INCREASED RISK OF NASH IN PATIENTS WITH DIABETES" at the The American Association of Clinical Endocrinologists (AACE) 24th Annual Scientific & Clinical Congress in Nashville, TN, May 13-17, 2015.]]>https://www.globenewswire.com/news-release/2015/04/30/730702/10131810/en/Medivo-to-Demonstrate-the-Value-of-Actionable-Lab-Data-at-Executive-War-College.html?f=22&fvtc=4&fvtv=25186Medivo to Demonstrate the Value of Actionable Lab Data at Executive War College2015-04-30T12:07:33Z<![CDATA[Jason Bhan, MD, Co-Founder and Chief Medical Officer, to discuss how real-time lab data analytics can impact laboratory revenues and patient outcomes NEW YORK, N.Y., April 30, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Medivo, Inc., a leader in lab data analytics, will present at the ]]>https://www.globenewswire.com/news-release/2015/04/16/725203/10129268/en/Medivo-to-Demonstrate-Correlation-of-Actionable-Lab-Data-to-Rx-Success-at-PMSA.html?f=22&fvtc=4&fvtv=25186Medivo to Demonstrate Correlation of Actionable Lab Data to Rx Success at PMSA2015-04-16T12:05:43Z<![CDATA[Poster Presentation at Pharmaceutical Management Science Association (PMSA) Meeting Demonstrates the Use of Lab Data Strategies to Accelerate New Product Adoption Using Lab Results Linked to Treatment Dispensed NEW YORK, N.Y., April 16, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Medivo, Inc., a leader in lab data analytics, will present a scientific poster at the Pharmaceutical Management Science Association (PMSA) Annual Conference, which is being held April 20-22, 2015, at the Hyatt Regency Crystal City in Arlington, Virginia.]]>https://www.globenewswire.com/news-release/2015/03/05/712734/10123464/en/Medivo-to-Showcase-Actionable-Insights-at-G2-Lab-Revolution-Conference.html?f=22&fvtc=4&fvtv=25186Medivo to Showcase Actionable Insights at G2 Lab Revolution Conference2015-03-05T13:12:05Z<![CDATA[Sundeep Bhan, Co-Founder and CEO, to demonstrate how real-time lab data analytics can impact patient outcomes. NEW YORK, N.Y., March 5, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Medivo's Co-Founder and CEO, Sundeep Bhan, will be presenting at the G2 Lab Revolution conference in Orlando, Fla. on March 13, 2015 at 11:15 AM ET during a session entitled, "The Big Deal with Big Data: Using Analytics to Unlock the Power of Lab Data." During his presentation, Mr. Bhan will demonstrate how Medivo's data analytics highlight opportunities to improve the outcomes of chronic myelogenous leukemia ("CML") patients through outreach and education.]]>